346 related articles for article (PubMed ID: 19544545)
1. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
Nguyen CT; Kattan MW
Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545
[TBL] [Abstract][Full Text] [Related]
2. An updated catalog of prostate cancer predictive tools.
Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
[TBL] [Abstract][Full Text] [Related]
3. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
Nguyen CT; Zelefsky MJ; Kattan MW
Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
[TBL] [Abstract][Full Text] [Related]
4. Inventory of prostate cancer predictive tools.
Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
Shariat SF; Karakiewicz PI; Suardi N; Kattan MW
Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454
[TBL] [Abstract][Full Text] [Related]
6. A catalog of prostate cancer nomograms.
Ross PL; Scardino PT; Kattan MW
J Urol; 2001 May; 165(5):1562-8. PubMed ID: 11342918
[TBL] [Abstract][Full Text] [Related]
7. Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.
Hammerer PG; Kattan MW; Mottet N; Prayer-Galetti T
BJU Int; 2006 Jul; 98(1):11-9. PubMed ID: 16566811
[TBL] [Abstract][Full Text] [Related]
8. Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
Valdagni R; Rancati T; Fiorino C
Cancer; 2009 Jul; 115(13 Suppl):3141-9. PubMed ID: 19544543
[TBL] [Abstract][Full Text] [Related]
9. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
10. Nomograms for bladder cancer.
Shariat SF; Margulis V; Lotan Y; Montorsi F; Karakiewicz PI
Eur Urol; 2008 Jul; 54(1):41-53. PubMed ID: 18207314
[TBL] [Abstract][Full Text] [Related]
11. Genomic approaches to outcome prediction in prostate cancer.
Febbo PG
Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
[TBL] [Abstract][Full Text] [Related]
12. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
Dahm P; Yeung LL; Chang SS; Cookson MS
J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
[TBL] [Abstract][Full Text] [Related]
13. Predictive models in diagnosing indolent cancer.
Bangma CH; Roobol MJ; Steyerberg EW
Cancer; 2009 Jul; 115(13 Suppl):3100-6. PubMed ID: 19544551
[TBL] [Abstract][Full Text] [Related]
14. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
[TBL] [Abstract][Full Text] [Related]
15. Predicting life expectancy in prostate cancer patients.
Jeldres C; Latouff JB; Saad F
Curr Opin Support Palliat Care; 2009 Sep; 3(3):166-9. PubMed ID: 19553817
[TBL] [Abstract][Full Text] [Related]
16. Biomolecular markers of outcome prediction in prostate cancer.
Lopergolo A; Zaffaroni N
Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
[TBL] [Abstract][Full Text] [Related]
17. A novel computer based expert decision making model for prostate cancer disease management.
Richman MB; Forman EH; Bayazit Y; Einstein DB; Resnick MI; Stovsky MD
J Urol; 2005 Dec; 174(6):2310-8. PubMed ID: 16280831
[TBL] [Abstract][Full Text] [Related]
18. Techniques and predictive models to improve prostate cancer detection.
Herman MP; Dorsey P; John M; Patel N; Leung R; Tewari A
Cancer; 2009 Jul; 115(13 Suppl):3085-99. PubMed ID: 19544550
[TBL] [Abstract][Full Text] [Related]
19. Predictive modeling in prostate cancer. Conclusions and reflections.
Denis LJ; Gospodarowicz MK
Cancer; 2009 Jul; 115(13 Suppl):3160-2. PubMed ID: 19544535
[TBL] [Abstract][Full Text] [Related]
20. High risk prostate cancer: evolving definition and approach to management.
Chughtai B; Mian BM
Can J Urol; 2008 Dec; 15(6):4375-80. PubMed ID: 19046490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
